Targeting the metabolism of cancer stem cells by energy disruptor molecules

Tahere Dadgar1, Nasim Ebrahimi2, Amir Reza Gholipour3

  • 1Department of Biology, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran.

Insights

Targeting cancer stem cells (CSCs) metabolism offers a novel cancer therapy. Disrupting CSC energy pathways can reduce tumor growth and resistance, paving the way for effective cancer treatment strategies.

Area of Science:

  • Oncology
  • Cancer Biology
  • Metabolic Research

Background:

  • Cancer stem cells (CSCs) drive tumor metastasis and therapy resistance.
  • Metabolic alterations are crucial for CSC survival and treatment resistance.
  • CSCs exhibit distinct metabolic pathways compared to normal and bulk tumor cells.

Purpose of the Study:

  • To highlight metabolic differences between CSCs and regular cancer cells.
  • To discuss the mechanisms of energy disruptors targeting CSC metabolism.
  • To explore novel therapeutic strategies for cancer treatment.

Main Methods:

  • Review of existing literature on CSC metabolism.
  • Analysis of metabolic pathways unique to CSCs.
  • Examination of energy disruptors' action mechanisms at cellular and molecular levels.

Main Results:

  • CSCs possess unique metabolic properties enabling alternative nutrient utilization.
  • Metabolic differences confer increased sensitivity of CSCs to agents disrupting cellular homeostasis.
  • Energy disruptors interfere with central metabolic pathways, reducing CSC survival.

Conclusions:

  • Targeting CSC metabolism represents a promising therapeutic strategy.
  • Understanding CSC metabolic vulnerabilities can lead to more effective cancer treatments.
  • Energy disruptors show potential for eliminating tumors by targeting CSCs.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K